These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 432836)

  • 1. [Evaluation of work capacity of patients with systemic lupus erythematosus and systemic scleroderma].
    Timeskov IS; Chirkina SS; Dolgobvorova KF; Gil'fanov RN; Zhuravleva SI
    Ter Arkh; 1979; 51(1):68-71. PubMed ID: 432836
    [No Abstract]   [Full Text] [Related]  

  • 2. [Assessment of the state of the cardiovascular system in the disability evaluation of patients with systemic lupus erythematosus and scleroderma].
    Zhabina TN; Morozova RZ; Otkalenko IuK
    Vrach Delo; 1977 Nov; (11):72-5. PubMed ID: 595566
    [No Abstract]   [Full Text] [Related]  

  • 3. [Work capacity of patients with systemic lupus erythematosus].
    Tarasov AN; Afanas'eva IK; Chirkina SS
    Vrach Delo; 1985 Jan; (1):81-5. PubMed ID: 3984335
    [No Abstract]   [Full Text] [Related]  

  • 4. [Work capacity assessment of systemic lupus erythematosus patients during the initial examination at the Medical Commission for Determination of Disability].
    Tarasov AN; Chirkina SS; Afanas'eva IK; Dolgodvorova KF; Prudnikov AM
    Ter Arkh; 1984; 56(5):36-9. PubMed ID: 6463884
    [No Abstract]   [Full Text] [Related]  

  • 5. [Systemic lupus erythematosus and lupoid diseases. Finding of typical LE cells in 2,000 patients with various internal and rheumatic diseases].
    Vachtenheim J
    Vnitr Lek; 1974 Sep; 20(9):877-88. PubMed ID: 4137470
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current immunological diagnosis of collagenoses. I. Systemic lupus erythematosus and systemic scleroderma].
    Jarzabek-Chorzelska M; Kołacińska-Strasz Z; Błaszczyk M; Chorzelski T; Jabłońska S
    Przegl Dermatol; 1987; 74(6):421-30. PubMed ID: 3330246
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rheumatic symptoms of scleroderma & lupus erythematosus].
    NAVA P
    Bras Med; 1956 May 5-26; 70(18-21):232-4. PubMed ID: 13460129
    [No Abstract]   [Full Text] [Related]  

  • 8. [Liquid crystal thermography of the hands in patients with visceral lupus erythematosus].
    Loreck D; Ihle E; Schmidt P; Apostoloff E; Heerdegen I; Bühler G
    Dermatol Monatsschr; 1987; 173(3):113-22. PubMed ID: 3595926
    [No Abstract]   [Full Text] [Related]  

  • 9. [Where does scleroderma begin?].
    Cayla J; Saporta L; Coste F
    Rev Rhum Mal Osteoartic; 1967 Dec; 34(12):711-3. PubMed ID: 5597833
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cross syndromes between systemic scleroderma and other connective tissue diseases].
    Guseva NG; Akhnazarova VD
    Ter Arkh; 1974; 46(11):70-8. PubMed ID: 4439290
    [No Abstract]   [Full Text] [Related]  

  • 11. Acquired ichthyosis associated with an overlap syndrome of systemic sclerosis and systemic lupus erythematosus.
    Lee HW; Ahn SJ; Choi JC; Chang SE; Choi JH; Moon KC; Koh JK
    J Dermatol; 2006 Jan; 33(1):52-4. PubMed ID: 16469086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diseases in which antinuclear antibody and-or rheumatoid factor are usually present. (Rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis).
    Sheon RP; Kirsner AB
    Med Times; 1973 Feb; 101(2):97-113. PubMed ID: 4539866
    [No Abstract]   [Full Text] [Related]  

  • 13. [Relation between 67-gallium scintigraphy and bronchoalveolar lavage--differential cell count and superoxide anion liberation--in patients with systemic scleroderma and systemic lupus erythematosus].
    Witt C; Apostoloff E; Müller GM; Buchali K; Hiepe F; Brenke A; Romberg B; Winsel K
    Pneumologie; 1992 Jan; 46(1):20-5. PubMed ID: 1312240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lupus erythematosus in cutaneous disseminated form with palmo-plantar localizations].
    Bureau Y; Barrière H; Litoux P; Bureau B
    Bull Soc Fr Dermatol Syphiligr; 1966; 73(4):428-9. PubMed ID: 5963671
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical characteristics and peculiarities of the course of severe collagenoses under the effect of hormonal therapy].
    Gubergrits AIa; Leĭnov LE; Tumanova AN
    Ter Arkh; 1968 Aug; 40(8):53-6. PubMed ID: 4393990
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dynamics of the work capacity of patients with variants of systemic lupus erythematosus, determined by the Expert Commission on Occupational Medicine].
    Tarasov AN; Chirkina SS; Shishkin VI; Prudnikov AM; Afanas'eva IK
    Ter Arkh; 1985; 57(8):85-8. PubMed ID: 4071438
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of scleroderma with L.E. cells and prolonged remission on cortisone therapy.
    VOLPE R; HAUCH JT
    Can Med Assoc J; 1955 Apr; 72(8):597-9. PubMed ID: 14364408
    [No Abstract]   [Full Text] [Related]  

  • 18. [Secondary lethal catastrophic antiphospholipid syndrome in 24-years old female patient with overlap syndrome (systemic sclerosis and systemic lupus erythematosus)].
    Ciołkiewicz M; Domysławska I; Kita K; Muklewicz E; Kowal-Bielecka O; Lewandowski B; Sierakowski S
    Pol Merkur Lekarski; 2006 Mar; 20(117):337-40. PubMed ID: 16780270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transitional types of scleroderma and dermatomyositis].
    Nishiyama S
    Naika; 1970; 25(5):831-4. PubMed ID: 5421839
    [No Abstract]   [Full Text] [Related]  

  • 20. [Letter: Suitability of immunofluorescence technics for the diagnosis of bullous eruptions, lupus erythematosus, and certain other dermatoses].
    Holubar K; Stingl G
    Hautarzt; 1976 Jan; 27(1):30-9. PubMed ID: 767302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.